Evidence map›Paper›PMID 41268023›Full record

ReviewVeterinary medicine international2025

Molecular Epidemiology and Control Strategies for BVDV: A Global Systematic Review From 2000 to 2025.

Eaftekhar Ahmed Rana, Jully Gogoi-Tiwari, Joshua Aleri, M Asaduzzaman Prodhan, Syeda H Akter, Henry Annandale, Subir Sarker, Sam Abraham, Jasim M Uddin

Abstract readReview
In one paragraph

Review in Veterinary medicine international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eaftekhar Ahmed RanaSchool of Veterinary Medicine, Murdoch University, Murdoch, Western Australia 6150, Australia.ORCID https://orcid.org/0000-0003-3648-1670
Jully Gogoi-TiwariSchool of Veterinary Medicine, Murdoch University, Murdoch, Western Australia 6150, Australia.
Joshua AleriSchool of Veterinary Science, The University of Queensland, Gatton, Queensland 4343, Australia.
M Asaduzzaman ProdhanSchool of Veterinary Medicine, Murdoch University, Murdoch, Western Australia 6150, Australia.
Syeda H AkterSchool of Veterinary Medicine, Murdoch University, Murdoch, Western Australia 6150, Australia.
Henry AnnandaleSchool of Veterinary Medicine, Murdoch University, Murdoch, Western Australia 6150, Australia.
Subir SarkerBiomedical Sciences & Molecular Biology, College of Medicine and Dentistry, James Cook University, Townsville, Queensland 4811, Australia.ORCID https://orcid.org/0000-0002-2685-8377
Sam AbrahamCentre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Murdoch, Western Australia 6150, Australia.
Jasim M UddinSchool of Veterinary Medicine, Murdoch University, Murdoch, Western Australia 6150, Australia.ORCID https://orcid.org/0000-0002-6732-5534

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bovine viral diarrhea virus (BVDV) remains a significant and highly contagious pathogen that markedly impacts production and reproductive performances of different animals worldwide. This review represents the global epidemiology of BVDV, emphasizing its genetic diversity, prevalence, host range, associated risk factors, diagnostic advancements, and control strategies. A systematic electronic search was performed to retrieve relevant published articles. A total of 248 studies published over the past 26 years (from January 2000 to March 2025) across 69 countries were included. Data showed that BVDV-1 has been detected across all the continents and comprises 25 subgenotypes (1a-1x and Chinese ZM-95), of which the predominant subgenotypes are 1a, 1b, and 1c. Multiple subgenotypes, such as BVDV-1f, 1g, 1h, 1k, 1l, 1r, 1s, 1t, 1u, and 1x, were distinct and circulating in European countries. Additionally, five subgenotypes (2a-2e) of BVDV-2 have been identified, with BVDV-2a being the most frequently reported in different geographical locations. Notably, the emergence of HoBi-like pestivirus subgenotypes (BVDV-3a-3d) has been detected in Russia, Italy, Thailand, India, and Bangladesh. Overall, the high prevalence of BVDV has been reported in various European (2.9%-87.1%) and Asian countries (0.2%-89.49%). Although cattle are the primary host, BVDV infections have been documented across a wide range of domestic and wild species, including buffalo, sheep, goats, deer, bison, yak, camelids (camels, alpacas, and llamas), pigs, and wild boar. While Ag/Ab-ELISA remains a widely used diagnostic method, advanced techniques, such as RT-qPCR, CRISPR-Cas12a, RT-LAMP, and genome sequencing, are utilized for confirmatory identification and genotyping of BVDV. Introduction of persistently infected (PI) animals into herds, grazing on common pasture, animal movements, mixed farming practices, and unhygienic breeding practices were frequently documented as potential risk factors. Key measures for controlling and eradicating BVDV include culling of PI animals, prophylactic vaccination, and avoiding mixed farming practices.

Indexed as

BVDVdiagnostic approachgenetic diversityhost diversityprevention and controlrisk factors

Identifiers

PMID41268023
PMCPMC12629698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.